[Hemodynamic effects of a new inhibitor of adrenergic beta receptors (LB 46)].
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000328:Adult; D000368:Aged; D000605:Amino Alcohols / Q000494:pharmacology; D000818:Animals; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D003327:Coronary Disease / Q000188:drug therapy; D004285:Dogs; D004562:Electrocardiography; D005260:Female; D006331:Heart Diseases / Q000188:drug therapy; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D066298:In Vitro Techniques; D007211:Indoles / Q000494:pharmacology*; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D013565:Sympatholytics / Q000494:pharmacology*
D000319:Adrenergic beta-Antagonists; D000605:Amino Alcohols; D007211:Indoles; D013565:Sympatholytics
Effets hémodynamiques d'un nouvel inhibiteur des bêta récepteurs adrénergiques (LB 46.